A new, improved DBS technique that targets specific subpopulations of neurons in the globus pallidus with short bursts of stimulation shows promising results as a treatment for Parkinson's disease.
A modified deep brain stimulation devise that delivers on-demand stimulation when it recognizes changes in brain patterns provides immediate and long-term relief for depression sufferers.
Deep brain stimulation appears to be safe, effective, and provides symptom improvements for at least one year in patients with treatment-resistant schizophrenia.
Researchers have successfully recorded brain signatures of movement symptoms and deep brain stimulation of Parkinson's patients in real time. The findings could lay the groundwork for personalize therapies for those with the neurodegenerative disease.
Researchers have succeeded in wirelessly recording both deep and surface human brain activity for an extended period of time while the patient was in their home environment.
Hippocampal deep brain stimulation prevented seizures in mouse models of temporal lobe epilepsy.
Spinal cord stimulation significantly decreased pain and reduced motor symptoms associated with Parkinson's disease, both as a singular therapy and for those who deep brain stimulation proved ineffective.
Targeted deep brain stimulation may help treat obsessive-compulsive disorder.
Researchers use optogenetic based deep brain stimulation to help treat motor dysfunction in animal models of Parkinson's disease. The new technique provides insights into why DBS works and ways in which it can be improved on a patient-by-patient basis.
Stimulating the central lateral thalamus in monkeys under anesthesia was enough to wake the animals and elicit normal waking behaviors.
Long term outcome data of patients with treatment-resistant depression found subcallosal cingulate deep brain stimulation (SCC DBS) was both effective at relieving symptoms and safe.
Sweat response could make brain stimulators more responsive for those with PTSD and other psychological disorders.
